Organization
Biogen
U.S. biotechnology company; maker of the Alzheimer's drug Aduhelm.
- Wikidata
- Q864338
Connections 2
produced
involved in
- FDA accelerated approval of Aduhelm (2021) sponsor of the drug Primary record 1
Proof 1 source
-
Maloney and Pallone Release Staff Report on Review, Approval, and Pricing of Biogen's Alzheimer's Drug Aduhelm, U.S. House Committee on Energy and Commerce, 29 Dec 2022.
Primary record
Biogen's Alzheimer's disease drug Aduhelm
FDA staff and Biogen engaged in at least 115 meetings, calls, and substantive email exchanges over a 12-month period beginning in July 2019.
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.